Trial Profile
Phase 2a proof of concept study of PIN-201104
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2022
Price :
$35
*
At a glance
- Drugs IRL 201104 (Primary)
- Indications Asthma
- Focus Proof of concept; Therapeutic Use
- 07 Dec 2018 New trial record
- 26 Nov 2018 According to an Immune Regulation media release, this trial is expected to begin in the second half of 2019.